World-class researchers flee Florey Institute as funds dry up
Three senior scientists including potential Nobel Prize contender Colin Masters have departed the Florey Institute after disputes over contracts, investigations and workplace culture.
The Florey Institute of Neuroscience and Mental Health, one of Melbourne's most prestigious research institutions, is losing top talent. Dr Ben Gu developed a urine-based Alzheimer's test now approved in 14 countries.
He left after a contract dispute and says the Florey refused to pay him patent royalties. Colin Masters, an Alzheimer's researcher tipped as a future Nobel laureate, departed following an integrity investigation.
Bradley Turner, a leading motor neurone disease researcher, resigned after legal action. Since 2022, the institute has run multimillion-dollar deficits.
Commercial revenues have nearly halved. Current and former staff describe a toxic workplace ruled by paranoia.
- 13
- Years at Florey
- 14
- Countries approving Alzheimer's test
- 2022
- Deficits since
- 10 of 14
- Victoria research institutes closing by
Why it mattersThe Florey is one of Melbourne's leading research institutions. Australia's other medical research institutes face similar financial pressure. Ten of Victoria's 14 are estimated to close by 2030.
AustraliaAustralia is losing leading scientists and medical research capability at a time when the sector is already under financial pressure.
Corroborated bytheage.com.au·watoday.com.au
✓ Claims checked against the source and corrected before publish. checked 3 h ago
